Interplay between C1-inhibitor and group IIA secreted phospholipase A2 impairs their respective function.

Autor: Ferrara, Anne Lise, Bova, Maria, Petraroli, Angelica, Marasco, Daniela, Payré, Christine, Fortuna, Sara, Palestra, Francesco, Ciardi, Renato, Marone, Gianni, Spadaro, Giuseppe, Lambeau, Gérard, Loffredo, Stefania
Zdroj: Immunologic Research; Feb2023, Vol. 71 Issue 1, p70-82, 13p
Abstrakt: High levels of human group IIA secreted phospholipase A2 (hGIIA) have been associated with various inflammatory disease conditions. We have recently shown that hGIIA activity and concentration are increased in the plasma of patients with hereditary angioedema due to C1-inhibitor deficiency (C1-INH-HAE) and negatively correlate with C1-INH plasma activity. In this study, we analyzed whether the presence of both hGIIA and C1-INH impairs their respective function on immune cells. hGIIA, but not recombinant and plasma-derived C1-INH, stimulates the production of IL-6, CXCL8, and TNF-α from peripheral blood mononuclear cells (PBMCs). PBMC activation mediated by hGIIA is blocked by RO032107A, a specific hGIIA inhibitor. Interestingly, C1-INH inhibits the hGIIA-induced production of IL-6, TNF-α, and CXCL8, while it does not affect hGIIA enzymatic activity. On the other hand, hGIIA reduces the capacity of C1-INH at inhibiting C1-esterase activity. Spectroscopic and molecular docking studies suggest a possible interaction between hGIIA and C1-INH but further experiments are needed to confirm this hypothesis. Together, these results provide evidence for a new interplay between hGIIA and C1-INH, which may be important in the pathophysiology of hereditary angioedema. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz: